# BayCom Corp: financial statements, quarterly

BCML · Nasdaq · CIK 1730984 · [Financials](/sectors/financials.md)

Pages: [Overview](/companies/bcml.md) · [Financials](/companies/bcml/financials.md) · [Filings](/companies/bcml/filings.md) · [Insiders](/companies/bcml/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bcml/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [8.0](/filings/0001730984-24-000087.md) | [8.7 d](/filings/0001730984-25-000017.md) | [9.3](/filings/0001558370-25-007192.md) | [10.1](/filings/0001730984-24-000065.md) | [10.6](/filings/0001730984-24-000087.md) | [10.6 d](/filings/0001730984-25-000017.md) | [9.8](/filings/0001558370-25-007192.md) | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [2.6](/filings/0001730984-24-000087.md) | [2.4 d](/filings/0001730984-26-000016.md) | [2.3](/filings/0001558370-25-007192.md) | [2.0](/filings/0001730984-25-000055.md) | [2.3](/filings/0001730984-25-000073.md) | [2.0 d](/filings/0001730984-26-000016.md) | [2.0](/filings/0001730984-26-000048.md) | [2.4](/filings/0001730984-26-000072.md) | [1.7](/filings/0001730984-25-000073.md) | [2.6 d](/filings/0001730984-26-000016.md) | [2.7](/filings/0001730984-26-000048.md) | [(0.2)](/filings/0001730984-26-000072.md) |
| Net income | $m | [6.6](/filings/0001730984-24-000087.md) | [6.4 d](/filings/0001730984-26-000016.md) | [5.9](/filings/0001558370-25-007192.md) | [5.6](/filings/0001730984-25-000055.md) | [6.0](/filings/0001730984-25-000073.md) | [6.1 d](/filings/0001730984-26-000016.md) | [5.7](/filings/0001730984-26-000048.md) | [6.4](/filings/0001730984-26-000072.md) | [5.0](/filings/0001730984-25-000073.md) | [6.9 d](/filings/0001730984-26-000016.md) | [8.2](/filings/0001730984-26-000048.md) | [(7.0)](/filings/0001730984-26-000072.md) |
| Diluted EPS | $ per share | [0.56](/filings/0001730984-24-000087.md) | not reported | [0.51](/filings/0001558370-25-007192.md) | [0.50](/filings/0001730984-25-000055.md) | [0.54](/filings/0001730984-25-000073.md) | not reported | [0.51](/filings/0001730984-26-000048.md) | [0.58](/filings/0001730984-26-000072.md) | [0.46](/filings/0001730984-25-000073.md) | not reported | [0.75](/filings/0001730984-26-000048.md) | [(0.64)](/filings/0001730984-26-000072.md) |
| Basic EPS | $ per share | [0.56](/filings/0001730984-24-000087.md) | not reported | [0.51](/filings/0001558370-25-007192.md) | [0.50](/filings/0001730984-25-000055.md) | [0.54](/filings/0001730984-25-000073.md) | not reported | [0.51](/filings/0001730984-26-000048.md) | [0.58](/filings/0001730984-26-000072.md) | [0.46](/filings/0001730984-25-000073.md) | not reported | [0.75](/filings/0001730984-26-000048.md) | [(0.64)](/filings/0001730984-26-000072.md) |

- Revenue: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [2,574](/filings/0001730984-23-000088.md) | [2,552](/filings/0001730984-25-000017.md) | [2,561](/filings/0001730984-24-000044.md) | [2,594](/filings/0001730984-24-000065.md) | [2,562](/filings/0001730984-24-000087.md) | [2,665](/filings/0001730984-26-000016.md) | [2,564](/filings/0001558370-25-007192.md) | [2,622](/filings/0001730984-25-000055.md) | [2,604](/filings/0001730984-25-000073.md) | [2,594](/filings/0001730984-26-000072.md) | [2,649](/filings/0001730984-26-000048.md) | [2,580](/filings/0001730984-26-000072.md) |
| Total liabilities | $m | [2,267](/filings/0001730984-23-000088.md) | [2,239](/filings/0001730984-25-000017.md) | [2,246](/filings/0001730984-24-000044.md) | [2,279](/filings/0001730984-24-000065.md) | [2,241](/filings/0001730984-24-000087.md) | [2,340](/filings/0001730984-26-000016.md) | [2,234](/filings/0001558370-25-007192.md) | [2,292](/filings/0001730984-25-000055.md) | [2,270](/filings/0001730984-25-000073.md) | [2,255](/filings/0001730984-26-000072.md) | [2,305](/filings/0001730984-26-000048.md) | [2,245](/filings/0001730984-26-000072.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [307](/filings/0001730984-24-000087.md) | [313](/filings/0001730984-26-000016.md) | [314](/filings/0001730984-25-000055.md) | [315](/filings/0001730984-25-000073.md) | [322](/filings/0001730984-25-000073.md) | [324](/filings/0001730984-26-000072.md) | [329](/filings/0001730984-26-000072.md) | [331](/filings/0001730984-26-000072.md) | [334](/filings/0001730984-25-000073.md) | [339](/filings/0001730984-26-000072.md) | [344](/filings/0001730984-26-000072.md) | [335](/filings/0001730984-26-000072.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [2,604 d](/filings/0001730984-24-000087.md) | [8,409 d](/filings/0001730984-26-000016.md) | [5,083](/filings/0001558370-25-007192.md) | [7,668 d](/filings/0001730984-25-000055.md) | [9,618 d](/filings/0001730984-25-000073.md) | [7,988 d](/filings/0001730984-26-000016.md) | [9,280](/filings/0001730984-26-000048.md) | [6,368 d](/filings/0001730984-26-000072.md) | [7,345 d](/filings/0001730984-25-000073.md) | [8,838 d](/filings/0001730984-26-000016.md) | [6,993](/filings/0001730984-26-000048.md) | [5,130 d](/filings/0001730984-26-000072.md) |
| Capital expenditure | $k | [532 d](/filings/0001730984-24-000087.md) | [1,420 d](/filings/0001730984-26-000016.md) | [1,143](/filings/0001558370-25-007192.md) | [245 d](/filings/0001730984-25-000055.md) | [255 d](/filings/0001730984-25-000073.md) | [58.0 d](/filings/0001730984-26-000016.md) | [143](/filings/0001730984-26-000048.md) | [749 d](/filings/0001730984-26-000072.md) | [1,116 d](/filings/0001730984-25-000073.md) | [(262) d](/filings/0001730984-26-000016.md) | [302](/filings/0001730984-26-000048.md) | [605 d](/filings/0001730984-26-000072.md) |
| Dividends paid | $k | [1,196 d](/filings/0001730984-24-000087.md) | [1,177 d](/filings/0001730984-26-000016.md) | [1,156](/filings/0001558370-25-007192.md) | [1,157 d](/filings/0001730984-25-000055.md) | [1,121 d](/filings/0001730984-25-000073.md) | [(59.0) d](/filings/0001730984-26-000016.md) | [1,669](/filings/0001730984-26-000048.md) | [0.0 d](/filings/0001730984-26-000072.md) | [2,201 d](/filings/0001730984-25-000073.md) | [2,730 d](/filings/0001730984-26-000016.md) | [3,267](/filings/0001730984-26-000048.md) | [3,265 d](/filings/0001730984-26-000072.md) |
| Share repurchases | $k | [4,520 d](/filings/0001730984-24-000087.md) | [2,440 d](/filings/0001730984-26-000016.md) | [3,998](/filings/0001558370-25-007192.md) | [4,131 d](/filings/0001730984-25-000055.md) | [1,084 d](/filings/0001730984-25-000073.md) | [34.0 d](/filings/0001730984-26-000016.md) | [1,306](/filings/0001730984-26-000048.md) | [3,881 d](/filings/0001730984-26-000072.md) | [909 d](/filings/0001730984-25-000073.md) | [813 d](/filings/0001730984-26-000016.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [13.3](/filings/0001730984-23-000088.md) | [12.7](/filings/0001730984-24-000044.md) | [12.2](/filings/0001730984-24-000065.md) | [11.8](/filings/0001730984-24-000087.md) | [11.5](/filings/0001558370-25-007192.md) | [11.3](/filings/0001730984-25-000055.md) | [11.1](/filings/0001730984-25-000073.md) | [11.1](/filings/0001730984-26-000048.md) | [11.0](/filings/0001730984-26-000072.md) | [10.9](/filings/0001730984-25-000073.md) | [10.9](/filings/0001730984-26-000048.md) | [10.9](/filings/0001730984-26-000072.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 10,920,117 at 2026-08-04, from the cover of the [10-Q filed 2026-08-10](/filings/0001730984-26-000072.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.